Bank Pictet & Cie (Europe)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-146,813
Closed -$14.9M 212
2025
Q4
$14.9M Sell
146,813
-14,864
-9% -$1.19M 0.3% 63
2025
Q3
$8.85M Sell
161,677
-1,527
-0.9% -$76.3K 0.18% 73
2025
Q2
$8.67M Buy
163,204
+34,914
+27% +$1.77M 0.19% 74
2025
Q1
$5.55M Sell
128,290
-734
-0.6% -$37.2K 0.13% 76
2024
Q4
$7.25M Buy
129,024
+1,547
+1% +$96.3K 0.16% 74
2024
Q3
$8.68M Sell
127,477
-8,200
-6% -$463K 0.21% 67
2024
Q2
$5.73M Sell
135,677
-28,962
-18% -$1.59M 0.14% 74
2024
Q1
$11.4M Buy
164,639
+31,339
+24% +$1.98M 0.3% 64
2023
Q4
$9.86M Buy
133,300
+13,369
+11% +$876K 0.29% 65
2023
Q3
$8.18M Buy
119,931
+6,801
+6% +$577K 0.29% 64
2023
Q2
$10.6M Sell
113,130
-29,664
-21% -$2.31M 0.36% 60
2023
Q1
$9.68M Sell
142,794
-574
-0.4% -$36.9K 0.4% 56
2022
Q4
$7.1M Buy
143,368
+6,655
+5% +$272K 0.35% 57
2022
Q3
$4.44M Sell
136,713
-441
-0.3% -$18.2K 0.22% 70
2022
Q2
$5.4M Sell
137,154
-16,900
-11% -$904K 0.25% 63
2022
Q1
$10.8M Buy
154,054
+1,769
+1% +$129K 0.41% 51
2021
Q4
$11.9M Sell
152,285
-131,783
-46% -$11.6M 0.4% 48
2021
Q3
$27.1M Buy
284,068
+9,021
+3% +$952K 1.01% 31
2021
Q2
$34.2M Buy
275,047
+182,599
+198% +$21.8M 1.19% 28
2021
Q1
$12.2M Buy
92,448
+36,745
+66% +$5.03M 0.49% 51
2020
Q4
$7.38M Sell
55,703
-6,561
-11% -$793K 0.36% 53
2020
Q3
$6.35M Sell
62,264
-102,955
-62% -$8.89M 0.36% 50
2020
Q2
$14.4M Buy
165,219
+52,397
+46% +$4.19M 1% 32
2020
Q1
$6.54M Buy
112,822
+109,312
+3,114% +$8.87M 0.59% 40
2019
Q4
$325K Buy
+3,510
New +$309K 0.05% 139

Other funds holding EXAS

Bank Pictet & Cie (Europe)'s EXAS Position: Q1 2026 in Review

Bank Pictet & Cie (Europe) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 146,813 shares — an estimated $14.9M sold.

Bank Pictet & Cie (Europe) first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $34.2M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bank Pictet & Cie (Europe) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 146,813 Exact Sciences shares in Q1 2026, an estimated $14.9M.
  • Bank Pictet & Cie (Europe) first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
  • Bank Pictet & Cie (Europe)'s Exact Sciences position peaked at $34.2M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2026, filed 14 Apr 2026.